ЭFFICACY AND TOLERABILITY OF LENVATINIB IN RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER. (2024). Western European Journal of Medicine and Medical Science, 2(6), 11-20. https://westerneuropeanstudies.com/index.php/3/article/view/1131